1558.HK Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Mai 2024 @ 10:08):

Stats
Tagesvolumen	1.96M
Durchschnittsvolumen	2.15M
Marktkapitalisierung	11.35B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	5.33
ATR14	HKD0.0170 (0.13%)

Volumen Korrelation

Lang: -0.21 (neutral)

Kurz: 0.48 (neutral)

Signal:(53.395) Neutral

YiChang HEC ChangJiang Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

YiChang HEC ChangJiang Korrelation - Währung/Rohstoff

0.14
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.25
( neutral )

-0.58
( weak negative )

-0.08
( neutral )

YiChang HEC ChangJiang Finanzdaten

Annual	2023
Umsatz:	HKD6.29B
Bruttogewinn:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
Umsatz:	HKD6.29B
Bruttogewinn:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
Umsatz:	HKD3.74B
Bruttogewinn:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
Umsatz:	HKD913.79M
Bruttogewinn:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.39%) | Divividend Growth Potential Score: 3.94 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	3.07	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	3.94
Div. Directional Score	6.59	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.07

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2289.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
1271.HK	Ex Dividend Junior	2023-08-10	Semi-Annually	0.00%
0322.HK	Ex Dividend Junior	2023-06-07	Annually	0.00%
6078.HK	Ex Dividend Knight	2023-06-30	Annually	0.00%
1830.HK	Ex Dividend Knight	2023-08-16	Annually	0.00%
0857.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0006.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
2611.HK	Ex Dividend Junior	2023-06-09	Annually	0.00%
1398.HK	Ex Dividend Junior	2023-07-06	Annually	0.00%
0460.HK	Ex Dividend Junior	2023-06-06	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.505	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	0.443	1.000	3.13	3.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.641	1.000	7.55	7.55	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.34	1.000	9.56	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.505	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.103	1.500	-4.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.266	1.000	5.85	0	[0.1 - 0.5]
Total Score				3.94

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.